Implementing an electronic medication overview in Belgium by Hannelore Storms et al.
Storms et al. BMC Research Notes 2014, 7:915
http://www.biomedcentral.com/1756-0500/7/915PROJECT NOTE Open AccessImplementing an electronic medication overview
in Belgium
Hannelore Storms1*, Kristel Marquet1, Katherine Nelissen1, Leen Hulshagen2, Jan Lenie2, Roy Remmen3
and Neree Claes1Abstract
Background: An accurate medication overview is essential to reduce medication errors. Therefore, it is essential to
keep the medication overview up-to-date and to exchange healthcare information between healthcare professionals
and patients. Digitally shared information yields possibilities to improve communication. However, implementing a
digitally shared medication overview is challenging. This articles describes the development process of a secured,
electronic platform designed for exchanging medication information as executed in a pilot study in Belgium,
called “Vitalink”.
Findings: The goal of “Vitalink” is to improve the exchange of medication information between professionals working
in healthcare and patients in order to achieve a more efficient cooperation and better quality of care. Healthcare
professionals of primary and secondary health care and patients of four Belgian regions participated in the project. In
each region project groups coordinated implementation and reported back to the steering committee supervising the
pilot study. The electronic medication overview was developed based on consensus in the project groups. The steering
committee agreed to establish secured and authorized access through the use of electronic identity documents (eID)
and a secured, eHealth-platform conform prior governmental regulations regarding privacy and security of healthcare
information.
Discussion: A successful implementation of an electronic medication overview strongly depends on the accessibility
and usability of the tool for healthcare professionals. Coordinating teams of the project groups concluded, based on
their own observations and on problems reported to them, that secured and quick access to medical data needed to
be pursued. According to their observations, the identification process using the eHealth platform, crucial to ensure
secured data, was very time consuming. Secondly, software packages should meet the needs of their users, thus be
adapted to daily activities of healthcare professionals. Moreover, software should be easy to install and run properly.
The project would have benefited from a cost analysis executed by the national bodies prior to implementation.
Keywords: General practice/family medicine, Quality of care, Health care organisation and management,
Communication, PharmacotherapyFindings
This article describes a pilot study called “Vitalink”, more
specifically the challenges encountered during develop-
ment and implementation [1]. The goal of this project is
to improve the exchange of information between pro-
fessionals working in healthcare and welfare in order to
achieve a more efficient cooperation and better quality of
care. Although aiming at a broad exchange of health and* Correspondence: Hannelore.storms@uhasselt.be
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unless otherwise stated.welfare information in the long run, medication manage-
ment was selected as the first domain to explore potential
improvement in communication amongst healthcare pro-
fessionals and patients.
Sharing information about one’s health is crucial to
ensure continuity and quality of care, therefore this pilot
study is of high importance [2-4]. By making medical re-
cords electronically accessible, healthcare information
can be consulted more easily by all healthcare profes-
sionals and by the patient. For all parties to have access
to a patient’s medical record is particularly important as
it improves its accuracy, which is a vital prerequisite toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Organization chart Vitalink.
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compliance [5-7]. Moreover, research shows that this re-
duction of medication errors through cooperation leads
to a decrease in hospital (re)admissions related to me-
dication errors [8]. Besides healthcare professionals, pa-
tients are, to some degree, capable to watch over the
level of accuracy of their medication record [9,10].
In accordance with previously published international
research [6,11], the Belgian healthcare knowledge center
stresses the importance of patient involvement to establish
a better communication between healthcare practitioners
[12]. In the research of Blenkinsopp et al. patient involve-
ment was also highlighted as they investigated (and con-
firmed) the use of paper notification cards, distributed by
patients to their general practitioner and pharmacists, as a
tool to improve communication [13]. However, the use of
a paper tool is perceived as very time consuming. An elec-
tronic medication overview could overcome this barrier
because it’s expected to be less time consuming and more
accessible for healthcare professionals [13]. The use of
electronic medication records is nevertheless facing other
challenges such as accessibility, usability and security is-
sues [4,14]. To evaluate Vitalink, coordinating teams of
the four project groups gathered data about these three
aspects via problems reported to them by users of the
electronic medication overview and through their own
observations.
Project outline
The pilot study of Vitalink was launched in January 2013
and ended in October 2013. This pilot study was executed
in four - governmentally appointed - regions in Belgium.
The development of the secured, electronic platform to
exchange medication information was intertwined with
the actual implementation of the digitally shared medica-
tion overview: no strict timeline was respected, decisions
and changes were made prior to as well as during imple-
mentation when problems arose. To establish a broad ex-
change of healthcare information, healthcare professionals
from across the healthcare system, as well as patient rep-
resentatives, were invited to participate in the project. In
each of the four regions a project group was assembled
with representatives from different professional associa-
tions (general practitioners, nursing staff and pharmacists)
and patient organizations. In some regions, there was also
representation from the local university. Oversight of the
project was confided to a steering group embed in a gov-
ernmental structure, called “working group ICT”. This
steering group resides under the “Collaborative Platform
Primary Health Care”, an advisory board of all stake-
holders in healthcare and welfare that advices the Minister
of Health and Welfare and debates on priorities to be set
out in health and welfare policy (Figure 1). Appointed
representatives of the four project groups (“coordinatingteams”) reported back to the steering committee about
the progress of Vitalink in their region.
Enrollment
Via the professional associations represented in the pro-
ject group, individual healthcare professionals of primary
care - general practitioners, pharmacists, nurses, home
care staff - and secondary care were informed about the
Vitalink project at local meetings. Given the explorative
character of the project, healthcare professionals could
enroll in Vitalink when interested in using the electro-
nic medication overview, but only if the software com-
pany of their routine software had developed a software
package supporting the Vitalink medication overview. In
contrast, inclusion of patients who were interested in
working with the electronic medication overview, was
carried out by the participating healthcare professionals.
Patients could only participate when having signed an
informed consent. Enrollment was not subjugated to a
final deadline: healthcare professionals and patients could
participate from the start in January 2013 to October 2013
because implementation of Vitalink progressed even after
the pilot study ended.
Software
Software companies were encouraged through financial
compensation by the government to develop an elec-
tronic medication overview for patients and healthcare
professionals involved in patients’ medication intake.
The content and lay-out of the medication overview was
discussed, modified and approved by all four project
groups. The Vitalink medication overview lists all pre-
scribed medication with name, dose, frequency, way of
administration and moment of intake (Figure 2).
Ethics
The study was approved by the Ethics Committees of
the Universities of Hasselt and Antwerp. An informed
consent to grant access to the medical record had to be
given by the patient to make it possible for healthcare
professionals to participate.
Figure 2 Vitalink medication overview.
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To exchange healthcare information, the steering com-
mittee decided, in close collaboration with the project
groups, on a secured connection as described hereafter.
Information itself is end to end encrypted. This means
that medication information is coded both when it is cen-
trally saved as when it is being transferred. When saving
information, the Vitalink connector inside the software
package encrypts the information by using a “session key”.
This session key is also coded using a public encryption
key. To read information two decryptors decode infor-
mation. One of them being signed to a central server,
designed to facilitate healthcare information exchange,
called the eHealth platform, the other controlled by the
“Cooperation Platform Primary Health Care”, making it
impossible for each organisation to encrypt information.Figure 3 Data transport in Vitalink.Only certain healthcare professionals and patients can
access the healthcare information (Figure 3). Moreover,
Vitalink registers every action that is performed on the
healthcare information, making it possible to detect
misuse of data.
Authorized access
Project groups agreed on authorization prior to ac-
cessing healthcare information as an additional security
warrantee. To have access to healthcare information the
steering committee agreed on an “opt-in system”. This
means that patients decide which healthcare professionals
can consult their healthcare information. This informed
consent can be changed by the patient at any point in
time. Consent will normally be given by reading patients’
electronic identity document (eID), in the pilot study
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committee also decided to build in a second authorization
check: Vitalink checks if the healthcare professional who
wants to access the healthcare information has a “thera-
peutic relationship” with the patient. This relationship too
has to be confirmed by the patient. Certain organisations,
for instance those of home care staff and nurses, don’t re-
quire this confirmation. Instead, Vitalink and the eHealth
platform check if the organization is authorized to access
certain healthcare information.
Even if access is granted by the patient, the steering
committee argued to still impose restrictions as to the
actions that can be performed and the data that are avail-
able to certain healthcare professionals. General practi-
tioners and pharmacists can create, consult and change
the medication overview, whereas home care staff, nurses
and secondary caregivers can only consult it. The patient
can only consult the electronic medication overview. The
process of consulting and changing the medication over-
view is described below.
Consulting medication overview
To consult the medication overview a patient needs prop-
erly installed software, an eID, an eID reader and a connec-
tion with Vitalink over the Internet. The eHealth platform
identifies the patient, sends the encrypted data to the pa-
tients’ computer, the software package decrypts the data
and the patient can read the file. Healthcare professionals
follow the same logging in procedure. eHealth identifies
the (type of) healthcare professional and sends a Security
Token Service-token (STS) valid for that session to the
software package of the healthcare professional. Vitalink
then checks the STS-token and retrieves information about
the relationship between these healthcare professionals
and the patient via the eHealth platform. Next, which
data are accessible to these healthcare professionals is veri-
fied. Those data can now be consulted, after decryption.
All these actions, including the identity of the healthcare
professional who wants access, are registered by Vitalink.
Changing medication overview
Only general practitioners and pharmacists were man-
dated to change – creating, adding, changing or deleting
data – the medication overview . The same procedure as
for consulting information is followed, with an additio-
nal verification whether changing the medication over-
view is allowed. If allowed, the changed or extra data are
encrypted using a “session key”, this session key is then
encrypted according to a public key. All these actions
are also registered by Vitalink.
Discussion
Coordinating teams of the four project groups gathered
data about the accessibility, usability and security issues.The reflection on Vitalink is based on the experiences of
the users of the electronic medication overview as re-
ported to the coordinating teams and on the teams own
observations.
Accomplishments and limitations
Vitalink is an innovative Belgian pilot study striving for
digitally exchanged healthcare information between dif-
ferent healthcare professionals and patients. The merit
of Vitalink is to have brought together different kinds of
stakeholders in healthcare in an exceptional cooperation.
Despite having to deal with time constraints, insufficient
resources and restrictions imposed by the government, a
lot was accomplished in a short time. One of the great-
est accomplishments was the development of a uniform
lay-out for the medication overview. However, the im-
plementation of the Vitalink project was subjected to
various software problems. Different kinds of software
packages needed to be developed, even within the same
healthcare profession, causing problems to implement a
uniform medication overview. Moreover, the Vitalink
medication overview was not easy to consult during home
visits. The requirements to have access to Vitalink, namely
having an eID, an eID reader and an Internet connection,
limit the accessibility of the medication overview. Vitalink
software was perceived as not being adjusted to the daily
practice of healthcare professionals, resulting in an extra
administrative burden. Data that were already saved in
healthcare professionals’ own electronic health records,
were not easily transferable to the Vitalink medication
overview, leading to a needless time investment. Secondly,
the security check designed to identify the healthcare pro-
fessional through communicating with the eHealth plat-
form, did not always work or took a lot of time, often
resulting in healthcare professionals aborting the proced-
ure. This security procedure made it also impossible for
general practitioners working in the same practice to ac-
cess the Vitalink medication overview that a colleague had
started.
Reflection
As described by Terry and colleagues, when implement-
ing new technology, it is essential to take into consider-
ation the needs of healthcare professionals and the time
investment to learn how to use the technology [14]. It
seems that the security of the Vitalink system prevailed
on the accessibility and consequently on the usability of
the Vitalink medication overview. When information
exchange between the healthcare professional’s software
and the eHealth platform interferes with the proceeding
of a patient’s consultation, the willingness to work with
the Vitalink medication overview diminishes. Further-
more, because access to the medication overview re-
quires the use of an eID reader, which is still not built
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tion overview gets compromised, in particular during
home visits. Also the need for an Internet connection poses
difficulties when visiting patients in their homes. All these
safety requirements, though important, can lead to an
extra administrative burden for healthcare professionals.
In turn possibly leading to demotivated healthcare profes-
sionals when it comes to working with this new technol-
ogy. One could question whether the far driven need for
data security jeopardizes the goal of this project: high
quality care and safe medication use for patients.
When software is not developed according to users’
needs and when security procedures prevent actually
working with the new medication overview, a lot of time
is wasted [14]. Working with maladjusted software and a
highly secured system in the end leads to a waste of
money as well [4]. When healthcare professionals spend
precious time learning how to work with new technol-
ogy or spend time waiting for this technology to work,
instead of being able to care for their patient, it seems
that money was not spent on software that adds value to
the care process. Necessary changes to adapt software in
accordance to healthcare professionals’ needs will be es-
sential to persuade healthcare professionals of the value
of an electronic medication overview. These changes ob-
viously will have its cost.
A sufficient financial investment would have been ne-
cessary to make a project like Vitalink run smoothly
from the beginning [2]. Moreover, a cost analysis should
have been carried out before implementing the project.
This cost analysis should have included an estimation
of the program and the personal cost [2]. These are the
costs to develop software according to healthcare pro-
fessionals’ needs, expenses for on-site training and the
time investment of healthcare professionals involved in
the project.Conclusion
A successful implementation of an electronic medication
overview strongly depends on the accessibility and us-
ability of the tool for healthcare professionals. Secured
and quick access to medical data needs to be pursued.
However, the identification process using the eHealth
platform, crucial to ensure secured data, was very time
consuming. Software packages should meet the needs of
their users, thus be adapted to daily activities of health-
care professionals. Moreover, they should be easy to
install and run properly. The project would have bene-
fited from a cost analysis executed by the national bodies
prior to implementation.
Abbreviations
eID: electronic identification document; ICT: Information and
Communications Technology; STS: Security Token Service-token.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HS: analyzed data, drafted manuscript. KM: drafted and revised manuscript
critically for important intellectual content. KN: revised manuscript critically
for important intellectual content. LH: revised manuscript critically for
important intellectual content. JL: revised manuscript critically for important
intellectual content. RR: revised manuscript critically for important intellectual
content. NC: drafted and revised manuscript critically for important
intellectual content. All authors read and approved the final manuscript.
They agree to be accountable for all aspects of the work in ensuring that
questions related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved.
Authors’ information
HS, KM, KN, NC: Hasselt University, Faculty of Medicine and Life Sciences.
LH, JL: Royal Union of Pharmacists of Limburg.
RR: University of Antwerp, Faculty of Medicine and Health Sciences.
NC: Antwerp Management School, Health Care Management.
Acknowledgements
The Vitalink project was financed by the Flemish government and setup by
the Flemish agency for Care and Health, an institute resorting under the
Flemish Ministry for Welfare, Public Health and Family.
Author details
1Faculty of Medicine and Life Sciences, Hasselt University, Campus
Diepenbeek, Agoralaan Building D, B-3590 Diepenbeek, Belgium. 2Koninklijk
Limburgs Apothekers Verbond (KLAV), Ilgatlaan 5, B-3500 Hasselt, Belgium.
3Faculty of Medicine and Health Sciences, University of Antwerp, Campus
Drie Eiken, Universiteitsplein 1, B-2610 Wilrijk, Belgium.
Received: 13 August 2014 Accepted: 11 December 2014
Published: 16 December 2014
References
1. Vitalink medicatieschema http://vimeo.com/41279683 (accessed at
December 18, 2013).
2. Claes N, Jacobs N, Van Mierlo J: The implementation of an electronic
cardiovascular risk calculator in general practice: a cost performance
study. Eur J Gen Pract 2010, 16:12–17.
3. Elliott RA, Tran T, Taylor SE, Harvey PA, Belfrage MK, Jennings RJ, Marriott JL:
Gaps in continuity of medication management during the transition
from hospital to residential care: an observational study (MedGap
Study). Australas J Ageing 2012, 31:247–254.
4. Iakovidis I: Towards personal health record: current situation, obstacles
and trends in implementation of electronic healthcare record in Europe.
Int J Med Inform 1998, 52:105–115.
5. Hillestad R, Bigelow J, Bower A, Girosi F, Meili R, Scoville R, Taylor R: Can
electronic medical record systems transform health care? Potential
health benefits, savings and costs. Health Aff 2005, 24:1103–1117.
6. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW:
Deficits in communication and information transfer between
hospital-based and primary care physicians: implications for patient
safety and continuity of care. JAMA 2007, 297:831–841.
7. Fitzgerald RJ: Medication errors: the importance of an accurate drug
history. Br J Clin Pharmacol 2009, 67:671–675.
8. Geurts MM, Talsma J, Brouwers JR, de Gier JJ: Medication review and
reconciliation with cooperation between pharmacist and general
practitioner and the benefit for the patient: a systematic review. Br J Clin
Pharmacol 2012, 74:16–33.
9. Chae SY, Chae MH, Isaacson N, James TS: The patient medication list: can
we get patients more involved in their medical care? J Am Board Fam
Med 2009, 22:677–685.
10. Ueckert F, Goerz M, Ataian M, Tessmann S, Prokosch H-U: Empowerment of
patients and communication with health care professionals through an
electronic health record. Int J Med Inform 2003, 70:99–108.
11. Bryanta LJM, Costera G, Gambleb GD, McCormick RN: The General
Practitioner–Pharmacist Collaboration (GPPC) study: a randomized
controlled trial of clinical medication reviews in community pharmacy.
Int J Pharm Pract 2011, 19(2):94–105.
Storms et al. BMC Research Notes 2014, 7:915 Page 6 of 6
http://www.biomedcentral.com/1756-0500/7/91512. Paulus D, Van den Heede K, Mertens R: Position Paper: Organisation of Care
for Chronic Patients in Belgium. Brussel: Federaal Kenniscentrum voor de
Gezondheidszorg; 2012:184. Report No.: 190C.
13. Blenkinsopp A, Jepson M, Drury M: Using a notification card to improve
communication between community pharmacists and general
practitioners. Br J Gen Pract 1991, 41:116–118.
14. Terry AL, Thorpe CF, Giles G, Brown JB, Harris SB, Reid GJ, Thind A, Stewart
M: Implementing electronic health records: key factors in primary care.
Can Fam Physician 2008, 54:730–736.
doi:10.1186/1756-0500-7-915
Cite this article as: Storms et al.: Implementing an electronic medication
overview in Belgium. BMC Research Notes 2014 7:915.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
